Background: Oropharyngeal mucositis occurs in virtually all patients with head and neck cancer receiving radiochemotherapy. The manipulation of the oral cavity microbiota represents an intriguing and challenging target. Patients and Methods: A total of 75 patients were enrolled to receive Lactobacillus brevis CD2 lozenges or oral care regimen with sodium bicarbonate mouthwashes. The primary endpoint was the incidence of grade 3 or 4 oropharyngeal mucositis during radiotherapy treatment. Results: There was no statistical difference in the incidence of grade 3-4 oropharyngeal mucositis between the intervention and control groups (40.6% vs. 41.6% respectively, p=0.974). The incidence of pain, dysphagia, body weight loss and quality of life were not different between the experimental and standard arm. Conclusion: Our study was not able to demonstrate the efficacy of L. brevis CD2 lozenges in preventing radiation-induced mucositis in patients with head and neck cancer. Although modulating homeostasis of the salivary microbiota in the oral cavity seems attractive, it clearly needs further study.Acute radiation-related toxicities represent a clinicallyrelevant problem during curative radiotherapy (RT) for patients with head and neck cancer (HNC). Among different side-effects, oropharyngeal mucositis (OM) remains one of the most important issues for patients with HNC, with a negative impact on their quality of life (QoL), and also on locoregional control due to the need for treatment breaks that extend the planned treatment time (1-6).The development of OM is complex and begins from clonogenic death of basal stem cells due to DNA strand breaks caused by reactive oxygen species (7). Through the complex activation of several transcription factors, it seems to end with the production of pro-inflammatory cytokines that promote and amplify cellular damage to the oral mucosa (8). Despite recent improvements in our understanding of these processes, preventive and therapeutic management of OM is still a debated and open question. A large number of 1935 This article is freely accessible online.Correspondence to:
The overall intra-institute and inter-institute agreement was moderate. Central lymph-node levels were the most critical and variability increased as the complexity of the patient's anatomy increased. These findings might have an effect on the interpretation of results from multicenter and even mono-institute studies.
Background
To report the long‐term outcome of patients undergoing re‐irradiation (re‐RT) for a recurrent or second primary head and neck cancer (RSPHNCs) in seven Italian tertiary centers, while testing the Multi‐Institution Reirradation (MIRI) recursive partitioning analysis (RPA) recently published.
Methods
We retrospectively analyzed 159 patients. Prognostic factors for overall survival (OS) selected by a random forest model were included in a multivariable Cox analysis. To externally validate MIRI RPA, we estimated the Kaplan‐Meier group‐stratified OS curves for the whole population.
Results
Five‐year OS was 43.5% (median follow‐up: 49.9 months). Nasopharyngeal site, no organ dysfunction, and re‐RT volume <36 cm3 were independent factors for better OS. By applying the MIRI RPA to our cohort, a Harrell C‐Index of 0.526 was found indicating poor discriminative ability.
Conclusion
Our data reinforce the survival benefit of Re‐RT for selected patients with RSPHNC. MIRI RPA was not validated in our population.
Objectives: To replace 5-fluorouracil with capecitabine within a trial of induction chemotherapy followed by cetuximab plus radiotherapy (RT) in patients with locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN). Also, to replace cisplatin with cetuximab after induction chemotherapy. Methods: Docetaxel and cisplatin were given at 75 mg/m2, while capecitabine was initially given at 500 mg/m2 twice a day and subsequently escalated. The maximum tolerated dose was used for the phase II study. Results: Seven patients were enrolled. At dose level 1, two dose-limiting toxicities were observed in the first 4 patients (grade 4 neutropenia and grade 3 diarrhea). In both patients, capecitabine was withdrawn and toxicities resolved. Dose escalation was halted and a lower capecitabine dose (750 mg/m2 daily) was selected. Two complete responses and five partial responses were observed after induction chemotherapy. Four patients were evaluable for response after cetuximab-RT (3 complete response and 1 partial response). Conclusion: Combined chemoradiotherapy is still the gold standard in LA SCCHN and no studies currently support the use of early induction chemotherapy. Our study did not contribute toward addressing this issue since it was discontinued early because of toxicity.
Purpose: The role of radiotherapy RT, particularly Stereotactic ablative body radiation therapy (SABRT), in the menagement of oligometastatic disease is currently estabilished for several primary tumors but no data about salivar gland cancer (SGC) have been pubblished yet. The aim of this study was to investigate the role of RT in oligometastatic SGC patients, focusing the attention on SABRT.Methods: We performed a retrospective, multicentric analasys of patients with oligometastatic SGC treated with palliative conventional RT or SABRT. Primary endopoint was the pattern of response of treated lesion according with RECIST criteria. In addiction, we have evaluated the local control (LC) of treated lesions comparing SABRT to conventonal RT.Results: Between 2006 and 2016, 64 patients were enrolled in 9 Italian Cancer Centers, on behalf of the Italian Association of Radiation Oncology (AIRO) Head and Neck Working Group. Thirty-seven patients (57.8%) were affected by Adenoid Cystic Carcinoma (ACC) and 27 patients (42.2%) were non-ACC. Thirtyfour patients underwent palliative RT (53,1%) and 30 had SABRT (46,9 %). The most common metastatic irradiated sites ware bone for palliative RT and lung for SABRT. Among patients treated with SABRT, an overall clinical benefit (Complete response, Partial Response and Stable disease) was observed in all treated lesions. In ACC histology group, the L C was better in metastatic lesions treated with SABRT.
Conclusion:We assessed the role of SABRT in the menagement of oligometastatic SGC patients. SABRT could be a valid alternative to control limited burden disease. It could delay systemic therapies,also considering the lack of effective systemic therapies in metastatic setting of SGCs.
Objectives: To determine interobserver variability in axillary nodal contouring in breast cancer (BC) radiotherapy (RT) by comparing the clinical target volume of participating single centres (SC-CTV) with a gold-standard CTV (GS-CTV). Methods: The GS-CTV of 3 patients (P1, P2, P3) with increasing complexity was created in DICOM format from the median contour of axillary CTVs drawn by BC experts, validated using the simultaneous truth and performance level estimation and peer-reviewed. GS-CTVs were compared with the correspondent SC-CTVs drawn by radiation oncologists, using validated metrics and a total score (TS) integrating all of them. Results: Eighteen RT centres participated in the study. Comparative analyses revealed that, on average, the SC-CTVs were smaller than GS-CTV for P1 and P2 (by −29.25% and −27.83%, respectively) and larger for P3 (by +12.53%). The mean Jaccard index was greater for P1 and P2 compared to P3, but the overlap extent value was around 0.50 or less. Regarding nodal levels, L4 showed the highest concordance with the GS. In the intra patient comparison, L2 and L3 achieved lower TS than L4. Nodal levels showed discrepancy with GS which was not statistically significant for P1, and negligible for P2, while P3 had the worst agreement. DICE Similarity Coefficient did not exceed the minimum threshold for agreement of 0.70 in all the measurements. Conclusions: Substantial differences were observed between SC- and GS-CTV, especially for P3 with altered arm set-up. L2 and L3 were the most critical levels. The study highlighted these key points to address. Advances in knowledge The present study compares, by means of validated geometric indexes, manual segmentationsof axillary lymph nodes in breast cancer from different observers and different institutionsmade on radiotherapy planning computed tomography images. Assessing such variability is ofparamount importance, as geometric uncertainties might lead to incorrect dosimetry andcompromise oncological outcome.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.